Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials
Novavax (NASDAQ:NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational ...
Becker's Hospital Review27d
FDA grants fast-track status to combination influenza and COVID-19 vaccine candidates
The FDA has ... and COVID-19, according to a Dec. 16 AJMC report. These vaccine candidates combine the flu vaccine with the Novavax COVID-19 vaccine, offering a potential single shot to address ...
Nasdaq1mon
NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines
The study will compare the immunogenicity and safety of the CIC vaccine with separate administrations of Novavax’s ... COVID/flu combination vaccines. Earlier today, SNY announced that the FDA ...
PMLiVE1mon
Sanofi receives FDA fast track designation for COVID-19/flu combination vaccines
Sanofi has announced that its two combination vaccine candidates for COVID-19 ... of Sanofi’s recombinant protein-based trivalent flu vaccine Flublok and the Novavax vaccine. The combination vaccines ...
Yahoo Finance1mon
NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines
The study will compare the immunogenicity and safety of the CIC vaccine with separate administrations of Novavax’s currently authorized COVID ... after the FDA lifted the clinical hold on ...